References

Acute respiratory distress syndrome

10.1038/s41572-019-0069-0 · 2019 · External reference

Sinomenine protects against E.coli-induced acute lung injury in mice through Nrf2-NF-κb pathway

10.1016/j.biopha.2018.08.048 · 2018 · External reference

The lipid biology of sepsis

10.1016/j.jlr.2021.100090 · 2021 · External reference

Role of oxylipins in cardiovascular diseases

10.1038/aps.2018.24 · 2018 · External reference

Bioactive lipid screening during respiratory tract infections with bacterial and viral pathogens in mice

10.1007/s11306-022-01898-4 · 2022 · External reference

Lipidomic profiling of bronchoalveolar lavage fluid extracellular vesicles indicates their involvement in lipopolysaccharide-induced acute lung injury

10.1159/000522338 · 2022 · External reference

Recent advances in lipidomics: analytical and clinical perspectives

10.1016/j.prostaglandins.2016.12.002 · 2017 · External reference

Current state-of-the-art of separation methods used in LC-MS based metabolomics and lipidomics

10.1016/j.jchromb.2021.123069 · 2022 · External reference

Characterization of changes in plasma and tissue oxylipin levels in LPS and CLP induced murine sepsis

10.1007/s00011-015-0897-7 · 2016 · External reference

Lipidomics study of sepsis-induced liver and lung injury under anti-HMGB1 intervention

10.1021/acs.jproteome.2c00851 · 2023 · External reference

The ARRIVE guidelines 2.0: updated guidelines for reporting animal research

2020 · External reference

VNS-mediated α7nAChR signaling promotes SPM synthesis via regulation of netrin-1 expression during LPS-induced ALI

2024 · External reference

Dexmedetomidine ameliorates endotoxin-induced acute lung injury in vivo and in vitro by preserving mitochondrial dynamic equilibrium through the HIF-1a/HO-1 signaling pathway

10.1016/j.redox.2021.101954 · 2021 · External reference

UHPLC-MS/MS-based untargeted lipidomics analysis of septic patients

10.1016/j.cca.2023.117336 · 2023 · External reference

Dynamics of pulmonary endothelial barrier function in acute inflammation: mechanisms and therapeutic perspectives

10.1007/s00441-014-1821-0 · 2014 · External reference

The cytokine storm of severe influenza and development of immunomodulatory therapy

10.1038/cmi.2015.74 · 2016 · External reference

Anti-inflammatory and anti-viral actions of anionic pulmonary surfactant phospholipids

2022 · External reference

Author correction: link between serum lipid signature and prognostic factors in COVID-19 patients

10.1038/s41598-022-07501-z · 2022 · External reference

Dynamic modulations of sphingolipids and glycerophospholipids in COVID-19

10.1002/ctm2.1069 · 2022 · External reference

Role of lipids in killing mycobacteria by macrophages: evidence for NF-kappaB-dependent and -independent killing induced by different lipids

10.1111/j.1462-5822.2008.01263.x · 2009 · External reference

The role of factors that regulate the synthesis and secretion of very-low-density lipoprotein by hepatocytes

10.1080/10408369891234246 · 1998 · External reference

Targeted metabolomics for discrimination of systemic inflammatory disorders in critically ill patients

10.1194/jlr.p023309 · 2012 · External reference

Pulmonary surfactant in health and human lung diseases: state of the art

10.1183/09031936.99.13614779 · 1999 · External reference

Phospholipid regulation of innate immunity and respiratory viral infection

10.1074/jbc.aw118.003229 · 2019 · External reference

Novel therapeutic roles for surfactant-inositols and -phosphatidylglycerols in a neonatal piglet ARDS model: a translational study

10.1152/ajplung.00128.2017 · 2018 · External reference

Comprehensive lipid profiling of bleomycin-induced lung injury

10.1002/jat.3758 · 2019 · External reference

Eicosanoids, β-cell function, and diabetes

10.1016/j.prostaglandins.2011.06.001 · 2011 · External reference

Resolvins and protectins in inflammation resolution

10.1021/cr100396c · 2011 · External reference

Role of basic science in the development of new medicines: examples from the eicosanoid field

10.1074/jbc.x112.351437 · 2012 · External reference

Resolution of acute inflammation in the lung

10.1146/annurev-physiol-021113-170408 · 2014 · External reference

Pro-resolving lipid mediators are leads for resolution physiology

10.1038/nature13479 · 2014 · External reference

Lipoxin A4 alleviates lung injury in sepsis rats through p38/MAPK signaling pathway

2020 · External reference

Lipoxin A4 reduces hyperoxia-induced lung injury in neonatal rats through PINK1 signaling pathway

10.1016/j.intimp.2019.05.046 · 2019 · External reference

Lipoxin A4 mitigates experimental autoimmune myocarditis by regulating inflammatory response, NF-κb and PI3K/Akt signaling pathway in mice

2017 · External reference

Annexin A1 mimetic peptide AC2-26 inhibits sepsis-induced cardiomyocyte apoptosis through LXA4/PI3K/AKT signaling pathway

10.1007/s11596-018-1975-1 · 2018 · External reference

CYP450-derived oxylipins mediate inflammatory resolution

10.1073/pnas.1521453113 · 2016 · External reference

Maresin biosynthesis and identification of maresin 2, a new anti-inflammatory and pro-resolving mediator from human macrophages

2014 · External reference

An integrated clinico-metabolomic model improves prediction of death in sepsis

10.1126/scitranslmed.3005893 · 2013 · External reference

Metabolomic derangements are associated with mortality in critically ill adult patients

10.1371/journal.pone.0087538 · 2014 · External reference

A pneumocyte-macrophage paracrine lipid axis drives the lung toward fibrosis

10.1165/rcmb.2014-0343oc · 2015 · External reference

Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis

10.2353/ajpath.2010.091082 · 2010 · External reference

Epoxyeicosatrienoic acids regulate macrophage polarization and prevent LPS-induced cardiac dysfunction

10.1002/jcp.24939 · 2015 · External reference